Literature DB >> 11939275

How practitioners (and others) can make scientifically viable contributions to clinical-outcome research using the single-case time-series design.

Jeffrey J Borckardt1, Michael R Nash.   

Abstract

Although clinicians typically possess considerable interest in research, especially about which interventions do and do not work, all too often they dismiss the notion that they themselves can make viable scientific contributions to the outcome literature. This derives from an unfortunate assumption that the only true experiment is a between-groups experiment. There is another form of true experiment that is perfectly compatible with real-world clinical practice: the single-case time-series design. Intensive and systematic tracking of one or a few patients over time can yield viable inferences about efficacy, effectiveness, and, under some circumstances, mechanism of change. This paper describes how clinicians working with hypnosis can carry out such research. The rationale and essential features of time-series studies are outlined; each design is illustrated with actual studies from the hypnosis literature; and new methods of statistical analysis, well within the statistical competence of practitioners, are described.

Entities:  

Mesh:

Year:  2002        PMID: 11939275     DOI: 10.1080/00207140208410095

Source DB:  PubMed          Journal:  Int J Clin Exp Hypn        ISSN: 0020-7144


  2 in total

1.  Charting a course for health services research at the National Institute on Drug Abuse.

Authors:  Wilson M Compton; Jack B Stein; Elizabeth B Robertson; Denise Pintello; Beverly Pringle; Nora D Volkow
Journal:  J Subst Abuse Treat       Date:  2005-10

2.  A randomized trial to examine the mechanisms of cognitive, behavioral and mindfulness-based psychosocial treatments for chronic pain: Study protocol.

Authors:  M A Day; D M Ehde; J Burns; L C Ward; J L Friedly; B E Thorn; M A Ciol; E Mendoza; J F Chan; S Battalio; J Borckardt; M P Jensen
Journal:  Contemp Clin Trials       Date:  2020-04-14       Impact factor: 2.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.